HGE CHRU Nancy

Vandœuvre-lès-Nancy 54500

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis

Studies at this site

• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — Completed